Skip to main content

Table 1 Characterization of the patients from Brazil, Latin America and World

From: Insulin Injection Technique Questionnaire: results of an international study comparing Brazil, Latin America and World data

 Characteristic

Brazil

N Brazil

LatAm

N LatAm

World

N World

T1DM

25%

64

31%

183

21%

2790

T2DM

73%

187

68%

408

41%

5378

Other/Not responded

2%

4

1%

8

38%

5057

 Age (years)

53.0 (18.9)

255

49.8 (20.1)

599

51.9 (18.1)

13,225

 BMI*

28.2 (6.1)

252

27.9 (6.0)

574

26.6 (6.2)

12,806

 Years with DM (years)

15.6 (9.5)

248

13.6 (9.6)

572

13.2 (9.7)

9197

 Age at diagnosis (years)

36.7 (17.5)

231

35.9 (18.3)

562

39.9 (7.2)

12,737

 Years on pills

14.8 (9.8)

148

13.3 (9.5)

272

8.3 (7.2)

6607

 Years on insulin

9.8 (8.5)

234

8.2 (7.9)

515

8.7 (8.9)

8242

 TDD regular (Units)

12.2 (9.8)

86

13.9 (9.9)

167

27.0 (20.7)

1422

 TDD rapid analogues

17.2 (11.5)

39

18.9 (11.4)

150

31.9 (21.6)

3467

 TDD NPH

39.3 (26.8)

219

37.6 (23.8)

391

31.6 (24.4)

1134

 TDD basal analogues

34.8 (14.7)

31

26.9 (13.1)

186

27.6 (19.5)

4709

 TDD premix

136

1

62.4 (48.3)

7

43.0 (25.3)

1796

 Overall TDD

45.9 (30.9)

242

42.5 (26.5)

579

48.5 (32.4)

7756

 HbA1c (%)

8.45 (1.8)

163

8.34 (1.8)

460

8.47 (2.1)

7663

  1. BMI body max index (calculated as the weight in kilograms divided by the height in meters squared), DM diabetes mellitus, T1DM type 1 diabetes mellitus, T2DM type 2 diabetes mellitus, TDD total daily dose, NPH neutral protamine Hagedorn, HbA1c glycated hemoglobin (%[mmol/mol])